general Archived signal

Xyra announces first patient dosed in europe in the phase 2 3 harbor af study of budiodarone in paroxysmal and persistent atrial fibrillation

GDELT indexed reporting associated with investigation involving Physician near Poland.

Reported by RECORDER.CA
Read the complete report at RECORDER.CA
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT EVOLUTION

1 recorded state

Signal first indexedP1 · 62% quality · 1 source

Explore this day in the archive →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.